Scarica l'app Stockscreener
44.01
2.20%
-0.99
Dopo l'orario di chiusura:
45.50
1.49
+3.39%
Terns Pharmaceuticals Inc Borsa (TERN) Ultime notizie
Biotech ETF SBIO Hovers Near Peak on Rally - ETF Database
Terns Pharmaceuticals raises $747.5 million in upsized offering - Traders Union
Terns Pharmaceuticals (TERN) climbs 53% on stellar leukemia treatment trial - MSN
Terns Pharmaceuticals (TERN) Climbs 53% on Stellar Leukemia Treatment Trial - Insider Monkey
Pharmaceutical Stocks To Follow TodayDecember 10th - MarketBeat
10 Stocks Delivering Explosive 18-190% Gains - Insider Monkey
Terns Pharma (TERN) Stock Analysis Report | Financials & Insights - Benzinga
symbol__ Stock Quote Price and Forecast - CNN
Terns Pharmaceutical prices stock at $40 per share - MSN
Terns Pharmaceuticals raises $747.5 million in public offering - Investing.com
Terns Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares - The Manila Times
Terns Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares - 富途牛牛
Terns Pharmaceuticals stock jumps after new leukemia drug data show strong patient responses - MSN
Citizens Analyst Raises Price Target for Terns Pharma (TERN) to $57.00 | TERN Stock News - GuruFocus
Terns Pharmaceuticals, Inc. Announces Upsized Public Offering - TradingView — Track All Markets
Terns Pharmaceuticals stock price target raised to $57 from $35 at Citizens - Investing.com Canada
Terns Pharmaceuticals Stock Surge: Analyzing the Leap - StocksToTrade
Jefferies raises Terns Pharmaceuticals stock price target to $70 on CML data - Investing.com Canada
Terns Pharmaceuticals Stock Soars After Leukemia Drug Delivers Big Early Responses In Tough-To-Treat Patients - Stocktwits
Terns Pharmaceuticals Stock Soars Amid Promising Drug Trial - TipRanks
TERN Upsizes Stock Offering to $502M - GuruFocus
Terns Pharmaceuticals (TERN) Announces Upsized Public Offering - GuruFocus
Why Terns Pharmaceuticals (TERN) Is Up 54.9% After Upsized $650 Million Equity Raise Following TERN-701 Data - Yahoo Finance
Terns Pharmaceuticals proposes $400M equity offering - MSN
Terns Pharmaceuticals Prices Upsized $650 Million Common Stock Offering - marketscreener.com
Terns Pharmaceuticals prices upsized $650 million public offering By Investing.com - Investing.com Nigeria
Terns Pharmaceuticals (TERN): Reassessing Valuation After CARDINAL CML Data Fuels Sharp Share Price Surge - Yahoo Finance
Terns Pharmaceuticals prices upsized $650 million public offering - Investing.com
Terns announces pricing of upsized $650 million public offering at $40 per share - marketscreener.com
Terns Announces Pricing of Upsized $650 Million Public Offering | Associated Press | syndication news - Enidnews.com
Terns Announces Pricing of Upsized $650 Million Public Offering - Yahoo Finance
Terns Pharmaceuticals Stock Skyrockets: Should You Dive In? - StocksToTrade
BMO Capital Maintains Terns Pharmaceuticals (TERN) Outperform Recommendation - Nasdaq
Terns (TERN) hits all-time high on stellar leukemia treatment results - MSN
Terns (TERN) Hits All-Time High on Stellar Leukemia Treatment Results - Finviz
Terns Pharmaceuticals: CML Data Blows Wall Street AwayAgain (NASDAQ:TERN) - Seeking Alpha
Oppenheimer Raises TERN Price Target by 107% to $58 | TERN Stock News - GuruFocus
Terns Pharma (TERN) Analyst Rating Update: Price Target Raised b - GuruFocus
Barclays Raises Terns Pharma (TERN) Price Target to $56 | TERN Stock News - GuruFocus
Terns Pharmaceuticals price target raised to $56 from $35 at Truist - TipRanks
Terns Pharmaceuticals stock rating reiterated by BMO Capital with $54 target - Investing.com South Africa
Terns Pharmaceuticals (TERN) Announces $400M Public Offering Pla - GuruFocus
Mizuho Raises Terns Pharma (TERN) Price Target to $54, Maintains Outperform Rating | TERN Stock News - GuruFocus
Oppenheimer Adjusts PT on Terns Pharmaceuticals to $58 From $28, Maintains Outperform Rating - marketscreener.com
Broadcom To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Tuesday - Benzinga
Terns Pharmaceuticals price target raised to $58 from $28 at Oppenheimer - TipRanks
Terns Pharmaceuticals (TERN) Launches $400M Public Offering - GuruFocus
Terns Pharmaceuticals price target raised to $54 from $33 at Mizuho - TipRanks
Truist Raises Price Target on Terns Pharmaceuticals to $56 From $35, Keeps Buy Rating - marketscreener.com
Mizuho Raises Price Target on Terns Pharmaceuticals to $54 From $33, Keeps Outperform Rating - marketscreener.com
Tiny Biotech Terns Takes Aim At Novartis' Leukemia Blockbuster - Benzinga
Terns Pharmaceuticals Launches $400 Million Stock, Warrant Offering - marketscreener.com
Terns Pharmaceuticals launches $400 million public offering By Investing.com - Investing.com Nigeria
H.C. Wainwright raises Terns Pharmaceuticals stock price target to $60 on CML drug data - Investing.com UK
Mizuho raises Terns Pharmaceuticals stock price target to $54 on CML drug data - Investing.com
0.36%
1.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):